Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

This study has been completed.
Information provided by:
Novartis Identifier:
First received: August 11, 2003
Last updated: February 25, 2011
Last verified: February 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)